Behavioral and biochemical investigations of bupropion metabolites
- PMID: 12909199
- DOI: 10.1016/s0014-2999(03)02010-7
Behavioral and biochemical investigations of bupropion metabolites
Abstract
The stimulus effects of bupropion metabolites were examined in a drug discrimination procedure using (-)nicotine- and (+)amphetamine-trained rats. (+)- and (-)threohydrobupropion partially substituted in each group. R,R-hydroxybupropion produced vehicle-appropriate responding in (-)nicotine animals but, when given in combination with the training dose of (-)nicotine, resulted in an attenuated effect. S,S-Hydroxybupropion partially (66%) substituted for (-)nicotine. In (+)amphetamine-trained animals, S,S-hydroxybupropion (ED50=4.4 mg/kg) generalized completely and was similar in potency to bupropion (ED50=5.4 mg/kg). Bupropion and its metabolites lacked affinity for nicotinic acetylcholinergic receptors, but all antagonized (-)nicotine-induced 86Rb+ efflux in cells expressing alpha3beta4 nicotinic cholinergic receptors. S,S-Hydroxybupropion possessed affinity at the dopamine transporter comparable to bupropion, and was also found to bind at the norepinephrine transporter. Although it is unlikely that any metabolite isomer is chiefly responsible for the stimulus actions of bupropion, some probably play a role in the complex actions of this agent.
Similar articles
-
Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):196-203. doi: 10.1097/FBP.0000000000000224. Behav Pharmacol. 2016. PMID: 26886209 Free PMC article.
-
Nicotine and bupropion share a similar discriminative stimulus effect.Eur J Pharmacol. 2002 May 17;443(1-3):113-8. doi: 10.1016/s0014-2999(02)01554-6. Eur J Pharmacol. 2002. PMID: 12044800
-
An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine.J Psychopharmacol. 2010 Jun;24(6):817-28. doi: 10.1177/0269881109102518. Epub 2009 Mar 20. J Psychopharmacol. 2010. PMID: 19304864 Free PMC article.
-
Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207. doi: 10.1111/j.1527-3458.2006.00178.x. CNS Drug Rev. 2006. PMID: 17227286 Free PMC article. Review.
-
Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects.Drug Metab Rev. 2019 Aug;51(3):293-313. doi: 10.1080/03602532.2019.1620763. Epub 2019 Jun 14. Drug Metab Rev. 2019. PMID: 31124380 Review.
Cited by
-
Nicotinic acetylcholine receptor variants are related to smoking habits, but not directly to COPD.PLoS One. 2012;7(3):e33386. doi: 10.1371/journal.pone.0033386. Epub 2012 Mar 15. PLoS One. 2012. PMID: 22438921 Free PMC article.
-
Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion using HPLC-MS/MS.J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Mar 15;1015-1016:201-208. doi: 10.1016/j.jchromb.2016.02.018. Epub 2016 Feb 18. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 26946423 Free PMC article.
-
Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model.Pharmaceutics. 2017 Dec 21;10(1):1. doi: 10.3390/pharmaceutics10010001. Pharmaceutics. 2017. PMID: 29267251 Free PMC article.
-
Transdermal delivery of bupropion and its active metabolite, hydroxybupropion: a prodrug strategy as an alternative approach.J Pharm Sci. 2009 Feb;98(2):583-94. doi: 10.1002/jps.21463. J Pharm Sci. 2009. PMID: 18623203 Free PMC article.
-
Central nervous system biogenic amine targets for control of appetite and energy expenditure.Endocrine. 2006 Feb;29(1):49-60. doi: 10.1385/endo:29:1:49. Endocrine. 2006. PMID: 16622292 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical